Subscribe to Search results

Armour stated they would never have any prison plasma.

Published on:

Alpha's president stated that while Alpha had purchased some plasma collected from homosexuals for Hepatitis B Gamma and Vaccine, they had never used it to make AHF.

Published on:

Alpha's president stated that Alpha had no centre in San Francisco.

Published on:

Alpha's internal memo stated Alpha did not collect plasma from penal institutions.

Published on:

Alpha's US medical director's letter to US haemophilia centres stated they did not operate prison donor centres which had a large high risk population nor did they purchase plasma from prisons.

Published on:

Dr Edward Shanbrom believed he was fired because of his strong objections to Hyland's use of plasma from Angola Prison in Louisiana on the basis of hepatitis risk at that prison.

Published on:

Alpha placed an advertisement in the Advocate The National Gay News Magazine for plasma donors and listed its plasma centre in San Francisco.

Published on:

Trimar Biologics's placed an advertisement to attract blood plasma donations from the gay population exposed to hepatitis for research and production of a vaccine.

Published on:

Alpha placed an advertisement to collect plasma from gay men exposed to hepatitis for use in the development of a hepatitis vaccine and listed a number of its plasma centres across the country.

Published on:

Hyland placed an advertisement offering to pay plasma donors for hepatitis B antibodies.

Published on:

A Lancet article suggested that non-A non-B Hepatitis might be associated with Hepatitis B infection.

Published on:

Hyland had had a policy that any plasma collected from a donor who had a history of hepatitis was excluded from use in the manufacture of AFH. Plasma with anti-HBs collected from homosexuals was sold to Alpha.

Published on:

A letter from the Vice President of Hyland stated that within the past several months, they had made a commitment to withhold from AFH manufacture any plasma obtained as a result of specific recruiting activities aimed at the gay community and they no longer allowed that plasma to enter the pools leading to AFH manufacture.

Published on:

At Alpha, the standard practice for most but not all plasma was to use the same plasma pool for the manufacture of Factor concentrates.

Published on:

The Office of Biologics through Dr Donohue raised concerns with Hyland regarding the use of plasma obtained through recruitment aimed at the gay community and requested assurance that such plasma would not be used in the manufacture of AFH for the time being.

Published on:

Dr Donohue requested all AFH manufacturers to voluntarily refrain from fractionating plasma into coagulation products if the plasma came from centers known to have a high population of homosexuals. Cutter placed a hold for one month and confirmation would be obtained from management to continue the hold. Dr Donohue felt that the hold would not be necessary for more than 2 or 3 months unless more donors developed AIDS.

Published on:

Alpha voluntarily suspended until further notice the use of cryoprecipitated materials from hepatitis B surface antibody donors in the manufacture of AFH.

Published on:

Alpha had recently closed its San Francisco centre.

Published on:

Alpha's Executive Committee agreed to report to the FDA the products produced from three units of plasma obtained from the 'AIDS donor' and to wait for FDA's opinion on what should be done with them.

Published on:

In On the Role of Sexual Behavior in the Spread of Hepatitis B Infection, it was noted that homosexual men should be advised not to give blood due to the high prevalence of identified and unidentified, blood-borne and sexually transmitted diseases.

Published on: